5728 East Boulevard
Vancouver, BC V6M 4M4
Full Time Employees: 18
|Mr. Anthony Tennyson||Co-founder, Pres, CEO & Director||55.24k||N/A||N/A|
|Dr. Benjamin Sessa B.Sc., MBBS||Co-founder, Chief Medical Officer, Member of Clinical Advisory Board & Director||85.53k||N/A||N/A|
|Mr. James Collins||Chief Operating Officer||7.83k||N/A||N/A|
|Dr. Shaun McNulty||Chief Scientific Officer & Member of Pre-Clinical Advisory Board||11.57k||N/A||N/A|
|Mr. George Scorsis||Co-founder & Chairman||N/A||N/A||1976|
|Mr. Jonathan James Held C.A., CPA, CA||Co-founder, CFO & Sec.||N/A||N/A||1986|
|Prof. David John Nutt DM, FMedSci, FRCP, FRCPsych, FSB, Ph.D.||Chair of Pre-Clinical & Clinical Advisory Board and Chief Research Officer||N/A||N/A||N/A|
|Prof. Celia Morgan||Head of Ketamine-Assisted Psychotherapy & Member of Clinical Advisory Board||N/A||N/A||N/A|
|Dr. Lowan H. Stewart||Regional Director of Nordics & MD of Awakn Oslo AS||N/A||N/A||N/A|
Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Vancouver, Canada.
Awakn Life Sciences Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.